Prevalence and clinical significance of antikeratin antibodies and other serological markers in lithuanian patients with rheumatoid arthritis

Annals of the Rheumatic Diseases

Volumn 60, Issue 5, 2001, Pages 459-466

  Vasiliauskiene, L ^b   Wiik, A ^a   Hoier Madsen M ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b VILNIUS UNIVERSITY   (Lithuania)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; BIOCHEMICAL MARKER; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; KERATIN ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; RHEUMATOID FACTOR;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISABILITY; DISEASE ACTIVITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LITHUANIA; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SEROLOGY;

ADULT; AGED; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, ANTINUCLEAR; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KERATINS; MALE; MIDDLE AGED; PREVALENCE; REGRESSION ANALYSIS; RHEUMATIC DISEASES; RHEUMATOID FACTOR;

EID: 0035015501     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.60.5.459     Document Type: Article

References (52)

1. The American Rheumatism Association 1987 revised criteria for the classifcation of rheumatoid arthritis
2. IgM rheumatoid factor (RF), IgA RF, IgE RF, and IgG RF detected by ELISA in rheumatoid arthritis
3. Characterization of the size and composition of circulating immune complexes in patients with rheumatoid arthritis
4. The rheumatoid factor: An analysis of clinical utility
5. Rheumatoid arthritis
6. Granulocyte-specific antinuclear factors in synovial fluids and sera from patients with rheumatoid arthritis
7. Anti-neutrophil cytoplasm antibodies in rheumatoid arthritis
8. Antineutrophil cytoplasmic antibodies in rheumatoid arthritis: Characterization and clinical correlations
9. Antineutrophil cytoplasmic antibodies (ANCA) in rheumatoid arthritis: A prospective study
10. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis
11. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: A marker of severe disease with associated nephropathy
12. Range of antinuclear antibodies in "healthy" individuals
13. A new serum factor in patients with rheumatoid arthritis: The antiperinuclear factor
14. Anti-keratin antibodies in rheumatoid arthritis
15. Antiperinuclear factor and keratin antibodies in rheumatoid arthritis
16. Anti-keratin antibodies in rheumatoid arthritis: Frequency and correlation with other features of the disease
17. Diagnostic value of antikeratin antibodies in rheumatoid arthritis
18. Significance of antikeratin antibodies in rheumatoid arthritis
19. Antikeratin antibodies in serum and synovial fluid show specificity for rheumatoid arthritis in a study of connective tissue diseases
20. Antikeratin antibodies in rheumatoid arthritis
21. High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat esophagus epithelium, so-called 'antikeratin antibodies'
22. Significance of laminar antikeratin antibodies to rat esophagus in rheumatoid arthritis
23. Antikeratin antibodies: Diagnostic and prognostic markers for early rheumatoid arthritis
24. Immunopathology of rheumatoid arthritis: Antikeratin antibodies precede the disease
25. The antiperinuclear factor (APF) and antikeratin antibodies (AKA) in rheumatoid arthritis
26. The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies
27. Anti-perinuclear factor compared with the so called "antikeratin" antibodies to human epidermis filaggrin, in the diagnosis of arthritides
28. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies
29. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide
30. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis
31. Therapeutic criteria in rheumatoid arthritis
32. Disease assessment and outcome in rheumatoid arthritis
33. Delineation of a standard procedure for indirect immunofluorescence detection of ANCA
34. Methods to detect autoantibodies to neutrophillc granulocytes
35. Detection of antinuclear antibodies by immunofluorescence
36. Autoantibodies to nuclear antigens (ANA): Their immunobiology and medicine
37. Determination of IgM rheumatoid factor by enzyme-linked immunosorbent assay (ELISA)
38. Enzyme-linked immunosorbent assay for determination of IgM rheumatoid factor
39. International reference preparation of rheumatoid arthritis serum
40. Purification of Wegener's granulomatosis autoantigen, proteinase 3, from neutrophils by triton X-114 extraction of azurophilic granules
41. Myeloperoxidase-mediated iodination in granulocytes
42. Comparison of heparin-binding to lactoferrin from human milk and from human granulocytes by means of affinity capillary electrophoresis
43. Mixed connective tissue disease - An apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA)
44. Microhaemagglutination test for detection of antibodies to "extractable nuclear antigen" (ENA). Comparative investigation in different groups of patients for ANA, DNA- and ENA-antibodies
45. Rheumatoid factor isotypes, disease activity and the outcome of rheumatoid arthritis
46. Clinical significance of rheumatoid factors in early rheumatoid arthritis: Results of follow-up study
47. Rheumatoid factor isotypes and severity of rheumatoid polyarthritis
48. IgA isotype rheumatoid factor in rheumatoid arthritis: Clinical implications
49. Prospective study of early rheumatoid arthritis. Prognostic value of IgA rheumatoid factor
50. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis
51. Anti-myeloperoxidase antibodies in patients with rheumatoid arthritis: Prevalence, clinical correlates, and IgG subclass
52. Anti-lactoferrin antibodies in patients with rheumatoid arthritis are associated with vasculitis